Epidiolex Clinical Trials

Epidiolex clinical trials tested a purified form of CBD to evaluate its safety and effectiveness in treating seizures associated with rare epilepsy syndromes like Lennox-Gastaut and Dravet syndrome. Participants included children and adults whose seizures were difficult to control with other medications. The studies found that Epidiolex significantly reduced seizure frequency with a generally favorable safety profile. These results supported its approval as a treatment option, providing new hope for people with these severe conditions.